Neumora Therapeutics Analyst Ratings
Neumora Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/10/2023 | 114.17% | Stifel | → $26 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月10日 | 114.17% | Stifel | →$26 | 開始承保 | →購買 |
What is the target price for Neumora Therapeutics (NMRA)?
Neumora治療公司(NMRA)的目標價格是多少？
The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by Stifel on October 10, 2023. The analyst firm set a price target for $26.00 expecting NMRA to rise to within 12 months (a possible 114.17% upside). 1 analyst firms have reported ratings in the last year.
Stifel於2023年10月10日報道了Neumora治療公司(納斯達克：NMRA)的最新目標價。這家分析公司將目標價定為26美元，預計NMRA將在12個月內升至(可能上漲114.17%)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Neumora Therapeutics (NMRA)?
Neumora治療公司(NMRA)的最新分析師評級是什麼？
The latest analyst rating for Neumora Therapeutics (NASDAQ: NMRA) was provided by Stifel, and Neumora Therapeutics initiated their buy rating.
紐莫拉治療公司(納斯達克代碼：NMRA)的最新分析師評級是由斯蒂費爾公司提供的，紐莫拉治療公司啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Neumora Therapeutics (NMRA)?
Neumora治療公司(NMRA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Neumora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Neumora Therapeutics was filed on October 10, 2023 so you should expect the next rating to be made available sometime around October 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Neumora Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Neumora治療公司的上一次評級是在2023年10月10日提交的，所以你應該預計下一次評級將在2024年10月10日左右的某個時候提供。
Is the Analyst Rating Neumora Therapeutics (NMRA) correct?
分析師對Neumora Treeutics(NMRA)的評級正確嗎？
While ratings are subjective and will change, the latest Neumora Therapeutics (NMRA) rating was a initiated with a price target of $0.00 to $26.00. The current price Neumora Therapeutics (NMRA) is trading at is $12.14, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Neumora治療公司(NMRA)評級是以0.00美元至26.00美元的目標價啟動的。Neumora Treateutics(NMRA)目前的交易價格為12.14美元，在分析師的預測範圍內。